CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, Gard, 30029, France
NCT Number: NCT01577511
The main objective of this study is to identify and characterize subpopulations of cells with invasive capacity in colorectal cancer from primary tumor, blood and metastatic samples.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nîmes, Gard, 30029, France
Secondary objectives include:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Samples: Peroperative blood sample plus primary and metastatic tumor biopsies.
Follow-up: disease outcomes assessed at 24 months
Time frame: Baseline (Day 0)
Time frame: baseline; day 0
Time frame: baseline; day 0
Time frame: baseline; day 0
Time frame: base line; day 0
right colon, left colon, transverse colon, sigmoid, rectum
Time frame: baseline, day 0
Time frame: baseline, day 0
Time frame: baseline, day 0
Time frame: baseline, day 0
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
living/deceased
Time frame: baseline; Day 0
Time frame: baseline; day 0
Time frame: baseline; day 0
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: baseline; day 0
Centre Hospitalier Universitaire de Nīmes
Other
Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer: Molecular Characterization and Implications for Therapeutic Strategies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06411756
Behavior, Colonic Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06370949
Colonic Diseases, Colorectal Cancer
Ankara, Cankaya, Turkey (Türkiye)
View Trial DetailsNCT05185947
Abdominal Neoplasms, Adenocarcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT07563816
Adenoma, Adenomatous Polyps
Hořovice, Czechia
View Trial Details